Findings from a postmarketing observational study showed an increased risk of GBS during the 42 days following vaccination.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

As for GBS itself, this neurological ailment can be severe, attacking nerves and warranting hospitalisation for weeks or ...

Regulators say, however, the benefits of vaccination with Abrysvo and Arexvy in preventing respiratory syncytial virus ...

The FDA has required the manufacturers of the RSV Vaccines Abrysvo and Arexvy to add a new warning to their labels about the ...

Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.

Novavax (NASDAQ:NVAX), and other vaccine developers extended recent gains on Tuesday as investors reacted to rising flu and ...

Investing.com -- The US Food and Drug Administration (FDA) on Tuesday directed that vaccines for a common respiratory virus ...

The Abrysvo vaccine protects infants – who are highly susceptible to respiratory syncytial virus (RSV) – against lower ...

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity -; primarily organ transplant recipients who take immunosuppressive medications to reduce the risk of ...

The vaccine Gretzky did promote, Arexvy, was the first FDA-approved vaccine to prevent RSV in older adults. According to the Centers for Disease Control and Prevention, during the first RSV season ...